Nutriband Inc (NTRB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $70.63M
Last updated: Nov 17, 2026 at 4:15 PM ET
Nutriband Inc (NTRB) Statistics
Nutriband (NTRB) has a market cap of $70.63M and an enterprise value of $67.36M. It kept -430.43% of revenue as net income over the last 12 months. Its share count is up 8.36% from a year earlier.
Total Valuation
Enterprise value is 4.63% below the market cap, as cash exceeds debt.
| Market Cap | $70.63M |
|---|---|
| Enterprise Value | $67.36M |
| Latest price (Nov 17, 2026) | $5.59 |
Key Dates
The next earnings report is set for Dec 9, 2026.
| Next Earnings Date | Dec 9, 2026 |
|---|---|
| Last Earnings Date | Sep 4, 2026 |
| Fiscal Year End | January |
Valuation Ratios
Sales and book value multiples are 42.0x and 12.8x. Its year-end P/S ranged from 9.6x to 124.0x from 2020 to 2025.
| P/S Ratio | 42.0x |
|---|---|
| P/B Ratio | 12.8x |
| P/TBV Ratio | 19.8x |
Price Statistics
The stock is up 1.64% over 52 weeks and trades 15.17% below its 50-day average.
| Beta (1Y) | 1.09 |
|---|---|
| 52-Week Change | +1.64% |
| 1-Month Change | -6.83% |
| 3-Month Change | +57.46% |
| 6-Month Change | +62.03% |
| 5-Year Change | +0.64% |
| Total Return (1Y) | +1.64% |
| Total Return (3Y CAGR) | +46.10% |
| Total Return (5Y CAGR) | +6.46% |
| Return vs SPY (1Y) | -2.17% |
| Max Drawdown (1Y) | -49.55% |
| Max Drawdown (3Y) | -67.23% |
| Sharpe Ratio (1Y) | 0.12 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $6.59 |
| 200-Day Average | $4.44 |
| 52-Week Range | $2.80 to $9.19 |
| RSI (14 Days) | 42.6 |
| Average Volume (20 Days) | 21.34K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.21x current liabilities, and total debt is 0.03x shareholder equity.
| Current Ratio | 4.21x |
|---|---|
| Quick Ratio | 4.02x |
| Debt / Equity | 0.03x |
| Interest Coverage | -338.51x |
Returns and Efficiency
Return on invested capital is -101.29% over the last 12 months, against a 5-year average of -71.56%.
| Return on Equity (ROE) | -130.67% |
|---|---|
| Return on Assets (ROA) | -110.64% |
| Return on Invested Capital (ROIC) | -101.29% |
| ROE (5Y Average) | -95.17% |
| ROA (5Y Average) | -83.64% |
| ROIC (5Y Average) | -71.56% |
| Asset Turnover | 0.20x |
| Inventory Turnover | 7.40x |
| Receivables Turnover | 123.37x |
| Cash Conversion Cycle | -164 days |
Scores
NTRB has an Altman Z-Score of 28.54, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 28.54 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.62M over the last 12 months is down 37.25% from the 12 months before.
| Revenue | $1.62M |
|---|---|
| Revenue Growth (YoY) | -37.25% |
| Gross Profit | $536.12K |
| Operating Income | -$7.05M |
| Pretax Income | -$6.96M |
| Net Income | -$6.96M |
| EBITDA | -$6.88M |
| Reported EPS (TTM) | -$0.51 |
Trailing 12 months through Jul 31, 2026.
Balance Sheet
Shareholder equity funds 84.74% of the $6.29M in total assets.
| Cash and Equivalents | $3.42M |
|---|---|
| Total Debt | $153.54K |
| Net Cash | $3.27M |
| Net Cash Per Share | $0.27 |
| Working Capital | $2.91M |
| Shareholder Equity | $5.33M |
| Book Value Per Share | $0.44 |
| Tangible Book Value | $3.44M |
| Tangible Book Per Share | $0.28 |
| Total Assets | $6.29M |
| Total Liabilities | $964.36K |
Balance sheet as of Jul 31, 2026.
Cash Flow
| Operating Cash Flow | -$3.63M |
|---|---|
| FCF Per Share | -$0.30 |
| Depreciation and Amortization | $146.44K |
Trailing 12 months through Jul 31, 2026.
Margins
The operating margin is -435.58%.
| Gross Margin | 33.14% |
|---|---|
| Operating Margin | -435.58% |
| Pretax Margin | -430.43% |
| Net Margin | -430.43% |
| EBITDA Margin | -425.45% |
| Gross Margin (5Y Average) | 35.09% |
Growth
Revenue fell 0.69% a year over 3 years.
| Revenue Growth (3Y CAGR) | -0.69% |
|---|---|
| Revenue Growth (5Y CAGR) | +16.63% |
Dividends and Yields
NTRB does not pay a dividend.
| Buyback Yield | 0.00% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-4 reverse split on Jul 24, 2019.
| Last Split Date | Jul 24, 2019 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:4 |
Peer Position
Against 6 similar companies, NTRB has the 2nd highest P/S.
P/S RatioPeer median 14.7x
ROICPeer median -106.71%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -15.25%
| P/S Ratio | 42.0x vs 14.7x median |
|---|---|
| ROIC | -101.29% vs -106.71% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -37.25% vs -15.25% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NTRB
What is NTRB's market cap?
Nutriband has a market cap of $70.63M. Its enterprise value, which adds debt and subtracts cash, is $67.36M.
How many shares of NTRB are outstanding?
Nutriband has 12.16M shares outstanding. The count is up 8.36% from a year earlier.
Does NTRB pay a dividend?
No. Nutriband does not pay a dividend.
How much debt does NTRB have?
Nutriband has $153.54K of total debt and $3.42M of cash and equivalents, a net cash position of $3.27M.
NTRB pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors